Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Obstet Med ; 17(2): 112-115, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38784192

ABSTRACT

We report our experience of managing a massive haemothorax caused by a ruptured, previously unknown, pulmonary arteriovenous malformation (pAVM) at 34 + 5 weeks of gestation, which proved to be a manifestation of hereditary haemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome. The patient underwent an emergency caesarean section under general anaesthesia after placement of a chest tube and gave birth to a healthy infant. A postoperative thoracic computed tomography angiography highlighted the presence of the large pAVM. Transcatheter embolization was performed right after the delivery. Subsequent patient's anamnesis, family history and genetic analysis finally revealed the presence of the syndrome. The aim of our report is to create awareness of this serious condition with potential life-threatening complications, especially in pregnancy. Simple criteria have been published and allow to easily consider HHT and the presence of potential AVM during anamnesis, ideally even before pregnancy.

2.
Int J Gynaecol Obstet ; 147(3): 339-343, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31502668

ABSTRACT

OBJECTIVE: To observe alterations in surgical planning that were due to the use of ulipristal acetate (UPA) 5 mg daily for symptomatic uterine fibroids. METHODS: A prospective cohort trial involving women with symptomatic fibroids was undertaken in 23 clinical practice sites within Belgium between October 1, 2014, and March 31, 2016, to compare initial surgical planning to performed surgical procedures following the use of UPA 5 mg daily for 3 months. Secondary outcomes were surgical complications, reduction in fibroids, bleeding control, and adverse effects. RESULTS: Two hundred and twenty-two women were recruited for the trial. The requirement for surgery decreased with the use of UPA, with 54% of women undergoing surgery after treatment. The reduction in surgery performed was lower for women willing to conceive (40%) compared to women who were not (49%). The volume of the fibroids decreased significantly, with the largest measured fibroid decreasing by 50%. Bleeding and pain were significantly decreased with the use of UPA. No major complications were recorded, and no liver function abnormalities were reported during the treatment and in follow-up. CONCLUSION: By administering UPA, the required rate of surgery was significantly decreased. Also, the resulting reduction in size of the fibroids could have the potential benefit of reducing surgery-related complications, and long-term use may be warranted to avoid surgery completely.


Subject(s)
Leiomyoma/drug therapy , Norpregnadienes/administration & dosage , Uterine Myomectomy/statistics & numerical data , Uterine Neoplasms/drug therapy , Adult , Belgium , Female , Humans , Preoperative Period , Prospective Studies , Treatment Outcome
3.
Front Surg ; 5: 79, 2018.
Article in English | MEDLINE | ID: mdl-30687715

ABSTRACT

Objectives: To evaluate the pregnancy and delivery rates of laparoscopic tubal reanastomosis. Study Design: From 2003 to 2013, 135 laparoscopic tubal reversals were performed according to the four stitch technique. The parameters studied, included positive pregnancy test, miscarriage, ectopic pregnancy, termination of pregnancy, term delivery, post-operative time to conception, post-operative hysterosalpingography, and spermogram. Results: From the 135 patients operated, 93 fulfilled the inclusion criteria. The age of patients varied from 27 to 47 years old. All ages combined, positive ß-HCG blood sample rate was 75.3% (95% CI: 65.0-83.4%) and term delivery 52.7% (95%CI: 42.1-3.0%). The age-adjusted pregnancy and delivery rates were as follows: 27-35 y.o. (n = 23) 95.7% (95%CI: 76.0-99.8%) and 73.9% (95%CI: 51.3-88.9%),36-39 y.o. (n = 40) 77.5% (95%CI: 61.1-88.6%) and 47.5% (95%CI: 31.8-63.7%),40-42 y.o. (n = 19) 68.4% (95%CI: 43.5-86.4%) and 52.6% (95%CI: 29.5-74.8%),43-47 y.o. (n = 11) 36.4% (95%CI: 12.4-68.4%) and 27.3% (95%CI: 7.3-60.7%). Conclusions: In our series the pregnancy and delivery rates after laparoscopic reversal of tubal sterilization is estimated at 75.3 and 52.7%, respectively. For women with tubal sterilization and no other infertility factors, reanastomosis can restore anterior natural fertility related to age. Laparoscopic reversal should be proposed systematically to patients and performed by well-trained laparoscopists, avoiding potentially the inconvenient and adverse outcomes of an IVF treatment. Although, it may seem a more cost-effective technique compared to robotically assisted reversal, a prospective randomized trial could answer this question.

SELECTION OF CITATIONS
SEARCH DETAIL
...